Adipogenesis as a Potential Anti-Obesity Target: A Review of Pharmacological Treatment and Natural Products

• Published in: Diabetes, metabolic syndrome and obesity Vol. 13; p. 67
• Main Authors: Jakab, Jelena, Miskic, Blazenka, Miksic, Stefica, Juranic, Brankica, Cosic, Vesna, Schwarz, Dragan, Vcev, Aleksandar
• Format: Journal Article
• Language: English
• Published: Dove Medical Press Limited 31.01.2021
• Subjects: Adipose tissues; Health aspects; Hypertension; Obesity; Type 2 diabetes; Croatia
• ISSN: 1178-7007; 1178-7007
• DOI: 10.2l47/DMSO.S281186

Obesity is recognized as a severe threat to overall human health and is associated with type 2 diabetes mellitus, dyslipidemia, hypertension, and cardiovascular diseases. Abnormal expansion of white adipose tissue involves increasing the existing adipocytes1 cell size or increasing the number through the differentiation of new adipocytes. Adipogenesis is a process of proliferation and differentiation of adipocyte precursor cells in mature adipocytes. As a key process in determining the number of adipocytes, it is a possible therapeutic approach for obesity. Therefore, it is necessary to identify the molecular mechanisms involved in adipogenesis that could serve as suitable therapeutic targets. Reducing bodyweight is regarded as a major health benefit. Limited efficacy and possible side effects and drug interactions of available anti-obesity treatment highlight a constant need for finding novel efficient and safe anti-obesity ingredients. Numerous studies have recently investigated the inhibitory effects of natural products on adipocyte differentiation and lipid accumulation. Possible anti-obesity effects of natural products include the induction of apoptosis, cell-cycle arrest or delayed progression, and interference with transcription factor cascade or intracellular signaling pathways during the early phase of adipogenesis. Keywords: adipogenesis, transcriptional cascades, signaling pathways, anti-obesity treatment, bioactive molecules